135 / 205
American Chemical Society (1996 - 2007)
American Society of Pharmacognosy (1997 - Present)
Phi Kappa Phi National Honors Society (2000 - Present)
Association of Analytical Chemists, International (AOAC, 2003 - Present)
SLV of Analytical Methods for Dietary Supplements (September, 2003)
Horwitz Advisor for AOAC (2004)
International Society for Horticultural Sciences (2005 - 2006)
Society for Medicinal Plant Research (GA) (2006 - 2007)
NIH NCCAM Grant Review Panel (2006)
Expert Review Panel AOAC – St. John’s Wort (2004, 2013)
Lutein/Zeaxanthin (2006)
Milk Thistle and Cranberry (2009)
Turmeric and Yohimbine (2010)
AHPA cGMP Working Group – (2007)
National Toxicology Program Review Panel (2008)
Natural Health Product Research Society of Canada (2009 – 2013)
CRN Government Relations Committee (2010 – 2013)
CRN Board of Director (2012 – 2013)
AOAC Stakeholder Panel on Strategic Food Analytical Methods (2011 – Present)
Chair of Flavonoid Working Group Committee (2011 – Present)
Scientific Advisory Group Member of NCA (2013 – Present)
AOAC Assist. Chair Stakeholder Panel on Dietary Supplements (2014 – Present)
ILSI Caffeine Committee (2015 – Present)
Publications
1.
Machonis, P.R.; Jones, M.A.;
Schaneberg, B.T.
; Kwik-Uribe, C. “Method for the
Determination of Catechin and Epicatechin Enantiomers in Cocoa-Based Ingredients and
Products by Liquid Chromatography: Single-Laboratory Validation”
Journal of AOAC
International
2012
, 95(2), 500.
2.
Ma, G.; Bavadekar, S.A.;
Schaneberg, B.T.
; Khan, I.A.; Feller, D.R.”Effects of
Synephrine and beta-Phenethylamine on Human alpha-Adrenoceptor Subtypes,”
Planta
Medica
2010
,
76
(10), 981.
3. Sorenson, W.R. and Sullivan, D. (Collaborators: Cain, T.; Chang, E.; Del Grosso, A.;
Goodridge, R.; Kou, X.; La Luzerne, P.; Landreth, B.; LeVansler, K.; Neal-Kababick, J.;
Paradis, B.;
Schaneberg, B.
; Shevchuk, C. “Determination of Aristolochic Acid I in
Botanicals and Dietary Supplements Potentially Contaminated with Aristolochic Acid I
Using LC-UV with Confirmation by LC/MS: Collaborative Study,”
Journal of AOAC
International
2007
,
90
(4), 925.
4.
Rimmer, C.A.; Howerton, S.B.; Sharpless, K.E.; Sander, L.C.; Long, S.E.; Murphy, K.E.;
Porter, B.J.; Putzback, K.; Rearick, M.S.; Wise, S.A.; Wood, L.J.; Zeisler, R.; Hancock,
D.K.; Yen, J.H.; Betz, J.M.; Nguyenpho, A.; Yang, L.; Scriver, C.; Willie, S.; Sturgeon,
R.;
Schaneberg, B.
; Nelson, C.; Skamarack, J.; Pan, M.; Levanseler, K.; Gray, D.;
Waysek, E.H.; Blatter, A.; Reich, E. “Characterization of a Suite of Gingko-Containing
Standard Reference Materials,”
Analysis of Bioanalytical Chemistry
2007
,
389
(1), 179.
5.
Ma, G.; Bavadekar, S.A.; David, Y.; Lalchandani, S.G.; Rangaswamy, N.;
Schaneberg,
B.T.
; Khan, I.A.; Feller, D.R. “Pharmacological Effects of Ephedrine Alkaloids on
Human
D
1
- and
D
2
- Adrenergic Receptor Subtypes,”
Journal of Pharmacology and
Experimental Therapeutics
2007
,
322
(1), 214.
AOAC OMB Teleconference Materials
135
11/09/2016